Armata Pharmaceuticals, Inc.
armatapharma.comWhat Do They Do?
Develops pathogen-specific bacteriophage drug candidates for patients with antibiotic-resistant and difficult-to-treat bacterial infections, including chronic lung and acute bloodstream infections.
10-K for FY2025, filed Mar 25, 2026We are a late clinical-stage biotechnology company focused on the development of high-purity and potency, pathogen-specific bacteriophage…View ↗
We are combining our proprietary approach and expertise in identifying, characterizing and developing both naturally occurring and…View ↗
In parallel to developing novel phage therapeutics that target chronic bacterial infections, we have an acute bacterial infection clinical…View ↗
Do Revenues Turn Into Profits?
No. It lost $173.8M in FY2025.
10-K for FY2025, filed Mar 25, 2026
−$36.6MView ↗
10-K for FY2025, filed Mar 25, 2026
−$173.8MView ↗
10-K for FY2025, filed Mar 25, 2026
−$26.3MView ↗
How Are They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Aug 12, 2026
$74.1MView ↗
- ▲ Now profitable
- vs −$16.3M in Q2 FY2025
-
Jul 20, 2026
David House appointed chief financial officer
House previously served as senior vice president of finance and principal financial officer.
Sources
8-K, filed Jul 20, 2026
On July 17, 2026, the Board of Directors (the “Board”) of Armata Pharmaceuticals, Inc. (the “Company”) promoted and appointed David House…View ↗
An acute lung-infection program
The earlier report focuses on chronic lung and bloodstream infections; the latest adds a preclinical program for acute ventilator-associated pneumonia and other severe Pseudomonas infections.
10-K for FY2022, filed Mar 16, 2023 10-K for FY2025, filed Mar 25, 2026Based on clinical findings with our intravenously administered S. aureus phage product candidate AP-SA02 (described below), and the…View ↗
Who Do They Compete With?
Competes with BiomX, Adaptive Phage Therapeutics, Intralytix, Locus Biosciences, and TechnoPhage
10-K for FY2025, filed Mar 25, 2026The majority of phage companies are focused on aspects outside of human health such as agriculture, food, environmental, veterinary…View ↗
Loading...
